Skip to main content
Top

Cancer and Metastasis Reviews

Issue 1-2/2019

Special Issue: Causes and Consequences of Tumor Acidosis

Content (26 Articles)

Preface

Robert J. Gillies

Intracellular pH dynamics and charge-changing somatic mutations in cancer

Katharine A. White, Kyle Kisor, Diane L. Barber

Imaging tumor acidosis: a survey of the available techniques for mapping in vivo tumor pH

Annasofia Anemone, Lorena Consolino, Francesca Arena, Martina Capozza, Dario Livio Longo

Molecular and functional imaging insights into the role of hypoxia in cancer aggression

Samata Kakkad, Balaji Krishnamachary, Desmond Jacob, Jesus Pacheco-Torres, Eibhlin Goggins, Santosh Kumar Bharti, Marie-France Penet, Zaver M. Bhujwalla

Extracellular acidity and increased exosome release as key phenotypes of malignant tumors

Mariantonia Logozzi, Enrico Spugnini, Davide Mizzoni, Rossella Di Raimo, Stefano Fais

Acidosis and proteolysis in the tumor microenvironment

Kyungmin Ji, Linda Mayernik, Kamiar Moin, Bonnie F. Sloane

Open Access Metastasis

Cause and effect of microenvironmental acidosis on bone metastases

Sofia Avnet, Gemma Di Pompo, Silvia Lemma, Nicola Baldini

Pro- and antitumor effects of mitochondrial reactive oxygen species

Valéry L. Payen, Luca X. Zampieri, Paolo E. Porporato, Pierre Sonveaux

Causes, consequences, and therapy of tumors acidosis

Smitha R. Pillai, Mehdi Damaghi, Yoshinori Marunaka, Enrico Pierluigi Spugnini, Stefano Fais, Robert J. Gillies

Radioimmunotherapy NON-THEMATIC REVIEW

Cancer-associated mucins: role in immune modulation and metastasis

Rakesh Bhatia, Shailendra K. Gautam, Andrew Cannon, Christopher Thompson, Bradley R. Hall, Abhijit Aithal, Kasturi Banerjee, Maneesh Jain, Joyce C. Solheim, Sushil Kumar, Surinder K. Batra

Pancreatic Cancer NON-THEMATIC REVIEW

Mucin glycoproteins block apoptosis; promote invasion, proliferation, and migration; and cause chemoresistance through diverse pathways in epithelial cancers

Ian S. Reynolds, Michael Fichtner, Deborah A. McNamara, Elaine W. Kay, Jochen H.M. Prehn, John P. Burke

Open Access Metastasis NON-THEMATIC REVIEW

Fugitives on the run: circulating tumor cells (CTCs) in metastatic diseases

Tania Mamdouhi, Julianne D. Twomey, K. Melodi McSweeney, Baolin Zhang

Clinical

Multiple treatment lines and prognosis in metastatic colorectal cancer patients

Chiara Carlomagno, Alfonso De Stefano, Mario Rosanova, Stefano De Falco, Laura Attademo, Giovanni Fiore, Sabino De Placido

CLINICAL

It is not just the drugs that matter: the nocebo effect

Marek Z. Wojtukiewicz, Barbara Politynska, Piotr Skalij, Piotr Tokajuk, Anna M. Wojtukiewicz, Kenneth V. Honn

Correction

Correction to: mTOR co-targeting strategies for head and neck cancer therapy

Zhiyong Wang, Juan Callejas Valera, Xuefeng Zhao, Qianming Chen, J. Silvio Gutkind

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine